Related Experiment Video
Updated: Jun 3, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
[Antifungal prophylaxis in HIV-seropositive liver transplant recipients]
1Servicio de Medicina Intensiva, Hospital Universitario Reina Sofía, Córdoba, España. juancarlos.pozo@ono.com
Background:
Seropositive human immunodeficiency virus (HIV) patients have a high prevalence of chronic liver disease for which liver transplantation is the only possible treatment. Risk of fungal infection in this population may be very high.
Case Report:
We describe the clinical course of the early postoperative period in a patient coinfected with HIV and hepatitis C virus undergoing liver transplantation. We discuss antifungal prophylaxis indications and drugs of choice in relation to their efficacy and safety profile. Other medical treatments are described, as well as possible pharmacokinetic interactions.
Conclusions:
Antifungal prophylaxis with anidulafungin has proven effective and has presented no significant adverse effects on a patient at high risk of fungal infection and multiple risk factors for drug interactions.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Kidney Transplant III: Nursing Management
Candidiasis
Kidney Transplant II: Surgical Procedure
Antiprotozoal Agents
